-
Abendroth A, Arvin A, 1999: Varicella-zoster virus immune evasion[J]. Immunological reviews, 168, 143-156. doi: 10.1111/j.1600-065X.1999.tb01289.x
-
Arvin A M, 1995: Aspects of the host response to varicella-zoster virus: a review of recent observations[J]. Neurology, 45, S36-37. doi: 10.1212/WNL.45.12_Suppl_8.S36
-
Arvin A M, 2001: Varicella-zoster virus: molecular virology and virus-host interactions[J]. Curr Opin Microbiol, 4, 442-449. doi: 10.1016/S1369-5274(00)00233-2
-
Chesnut G, McClain D, Galeckas K, 2012: Varicella-zoster virus in children immunized with the varicella vaccine[J]. Cutis, 90, 114-116.
-
Choo P W, Donahue J G, Manson J E, Platt R, 1995: The epide-miology of varicella and its complications[J]. J Infect Dis, 172, 706-712. doi: 10.1093/infdis/172.3.706
-
Cohen J I, Seidel K E, 1993: Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro[J]. Proc Natl Acad Sci U S A, 90, 7376-7380. doi: 10.1073/pnas.90.15.7376
-
Cole N L, Grose C, 2003: Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus[J]. Rev Med Virol, 13, 207-222. doi: 10.1002/rmv.377
-
Collaco A M, Rahman S, Dougherty E J, Williams B B, Geusz M E, 2005: Circadian regulation of a viral gene promoter in live transgenic mice expressing firefly luciferase[J]. Mol Imaging Biol, 7, 342-350. doi: 10.1007/s11307-005-0019-y
-
Contag C H, Bachmann M H, 2002: Advances in in vivo biolumin-escence imaging of gene expression[J]. Annu Rev Biomed Eng, 4, 235-260. doi: 10.1146/annurev.bioeng.4.111901.093336
-
Contag C H, Spilman S D, Contag P R, Oshiro M, Eames B, Dennery P, Stevenson D K, Benaron D A, 1997: Visualizing gene expression in living mammals using a bioluminescent reporter[J]. Photochem Photobiol, 66, 523-531. doi: 10.1111/j.1751-1097.1997.tb03184.x
-
Doyle T C, Burns S M, Contag C H, 2004: In vivo biolumine-scence imaging for integrated studies of infection[J]. Cell Micro-biol, 6, 303-317. doi: 10.1111/j.1462-5822.2004.00378.x
-
Drolet M, Brisson M, Schmader K E, Levin M J, Johnson R, Oxman M N, Patrick D, Blanchette C, Mansi J A, 2010: The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study[J]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 182, 1731-1736. doi: 10.1503/cmaj.091711
-
Dulal K, Zhang Z, Zhu H, 2009: Development of a gene cap-ture method to rescue a large deletion mutant of human cytomegalovirus[J]. Journal of Virological Methods, 157, 180-187. doi: 10.1016/j.jviromet.2008.12.021
-
Dulal K, Silver B, Zhu H. 2012. Use of Recombination-Mediated Genetic Engineering for Construction of Rescue Human Cytomegalovirus Bacterial Artificial Chromosome Clones. Biomed and Biotechnol.
-
Fan S, Maguire C A, Ramirez S H, Bradel-Tretheway B, Sapinoro R, Sui Z, Chakraborty-Sett S, Dewhurst S, 2005: Valproic acid enhances gene expression from viral gene transfer vectors[J]. J Virol Methods, 125, 23-33. doi: 10.1016/j.jviromet.2004.11.023
-
Gershon M D, Gershon A A, 2010: VZV infection of keratinocytes: production of cell-free infectious virions in vivo[J]. Curr Top Microbiol Immunol, 342, 173-188.
-
Gilden D H, Kleinschmidt-DeMasters B K, LaGuardia J J, Maha-lingam R, Cohrs R J, 2000: Neurologic complications of the reactivation of varicella-zoster virus[J]. N Engl J Med, 342, 635-645. doi: 10.1056/NEJM200003023420906
-
Harnisch J P, 1984: Zoster in the elderly: clinical, immunologic and therapeutic considerations[J]. J Am Geriatr Soc, 32, 789-793. doi: 10.1111/j.1532-5415.1984.tb06298.x
-
Hastings J W, 1983: Biological diversity, chemical mechanisms, and the evolutionary origins of bioluminescent systems[J]. J Mol Evol, 19, 309-321. doi: 10.1007/BF02101634
-
Hatchette T, Tipples G A, Peters G, Alsuwaidi A, Zhou J, Mailman T L, 2008: Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature[J]. Pediatr Infect Dis J, 27, 75-77. doi: 10.1097/INF.0b013e3181598315
-
Kimberlin D W, Whitley R J, 2007: Varicella-zoster vaccine for the prevention of herpes zoster[J]. N Engl J Med, 356, 1338-1343. doi: 10.1056/NEJMct066061
-
Klassen T P, Hartling L, Wiebe N, Belseck E M. 2005. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database Syst Rev: CD002980.
-
Kurfurst M, Ghisla S, Hastings J W, 1983: Bioluminescence emission from the reaction of luciferase-flavin mononucleotide radical with O2[J]. Biochemistry, 22, 1521-1525. doi: 10.1021/bi00276a001
-
Leung J, Harpaz R, Molinari N A, Jumaan A, Zhou F, 2011: Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination[J]. Clin Infect Dis, 52, 332-340. doi: 10.1093/cid/ciq077
-
Liesegang T J, 2004: Herpes zoster virus infection[J]. Curr Opin Ophthalmol, 15, 531-536. doi: 10.1097/01.icu.0000143686.68103.46
-
Lydick E, Epstein R S, Himmelberger D, White C J, 1995: Herpes zoster and quality of life: a self-limited disease with severe impact[J]. Neurology, 45, S52-53.
-
Nagaike K, Mori Y, Gomi Y, Yoshii H, Takahashi M, Wagner M, Koszinowski U, Yamanishi K, 2004: Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chro-mosome in Escherichia coli[J]. Vaccine, 22, 4069-4074. doi: 10.1016/j.vaccine.2004.03.062
-
Niizuma T, Zerboni L, Sommer M H, Ito H, Hinchliffe S, Arvin A M, 2003: Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model[J]. J Virol, 77, 6062-6065. doi: 10.1128/JVI.77.10.6062-6065.2003
-
Opstelten W, Mauritz J W, de Wit N J, van Wijck A J, Stalman W A, van Essen G A, 2002: Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database[J]. Fam Pract, 19, 471-475. doi: 10.1093/fampra/19.5.471
-
Rehemtulla A, Stegman L D, Cardozo S J, Gupta S, Hall D E, Contag C H, Ross B D, 2000: Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging[J]. Neoplasia, 2, 491-495. doi: 10.1038/sj.neo.7900121
-
Reichelt M, Zerboni L, Arvin A M, 2008: Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia[J]. J Virol, 82, 3971-3983. doi: 10.1128/JVI.02592-07
-
Saksena M M, Wakisaka H, Tijono B, Boadle R A, Rixon F, Takahashi H, Cunningham A L, 2006: Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons[J]. J Virol, 80, 3592-3606. doi: 10.1128/JVI.80.7.3592-3606.2006
-
Uebe B, Sauerbrei A, Burdach S, Horneff G, 2002: Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child[J]. Eur J Pediatr, 161, 442-444. doi: 10.1007/s00431-002-0981-1
-
Vazquez M, 2004: Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine[J]. Curr Opin Pediatr, 16, 80-84. doi: 10.1097/00008480-200402000-00015
-
Warden C, Tang Q, Zhu H, 2011: Herpesvirus BACs: past, present, and future[J]. J Biomed Biotechnol, , 124595-.
-
Warming S, Costantino N, Court D L, Jenkins N A, Copeland N G, 2005: Simple and highly efficient BAC recombineering using galK selection[J]. Nucleic Acids Res, 33, e36-. doi: 10.1093/nar/gni035
-
White M R, Masuko M, Amet L, Elliott G, Braddock M, Kingsman A J, Kingsman S M, 1995: Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells[J]. J Cell Sci, 108, 441-445.
-
Whitley R J, 2005: Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination[J]. J Infect Dis, 191, 1999-2001. doi: 10.1086/430328
-
Yih W K, Brooks D R, Lett S M, Jumaan A O, Zhang Z, Clements K M, Seward J F, 2005: The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003[J]. BMC Public Health, 5, 68-. doi: 10.1186/1471-2458-5-68
-
Zerboni L, Arvin A, 2011: Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts[J]. J Neurovirol, 17, 570-577. doi: 10.1007/s13365-011-0066-x
-
Zerboni L, Reichelt M, Arvin A, 2010: Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts[J]. Curr Top Microbiol Immunol, 342, 255-276.
-
Zhang Y, Muyrers J P, Testa G, Stewart A F, 2000: DNA cloning by homologous recombination in Escherichia coli[J]. Nat Biotechnol, 18, 1314-1317. doi: 10.1038/82449
-
Zhang Z, Huang Y, Zhu H, 2008: A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system[J]. J Virol Methods, 148, 197-204. doi: 10.1016/j.jviromet.2007.11.012
-
Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H, 2007: Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system[J]. J Virol, 81, 9024-9033. doi: 10.1128/JVI.02666-06
-
Zhang Z, Selariu A, Warden C, Huang G, Huang Y, Zaccheus O, Cheng T, Xia N, Zhu H, 2010: Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor[J]. PLoS pathogens, 6, e1000971-.